United Effort Towards an HIV Cure
CRISPR for Cure is 1 of 10 Martin Delaney Collaboratories for HIV Cure in the country. We use cutting edge technology in basic and translational HIV cure research.
Searching for a cure for the 38 million people living with HIV
It has been over 40 years since the first reported case of HIV and today we are closer to a cure than ever.
Our goal is to implement a genetic strategy using CRISPR gene editing platform for the permanent inactivation of HIV and enhancement of the immune system.

Collaborating for success
It takes a village to find an HIV cure. CRISPR for Cure is a highly collaborative and synergistic research program with academic, industry, government, and community partnerships.
Upcoming
Event
May 13, 2022: Webinar presented by Dr. Frederick Kizito on “Structural rearrangements in the nucleus localize latent HIV proviruses to a perinuclear zone supportive of early transcription reactivation”